AI
LVGO

ArchPoint Investors’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

ArchPoint Investors’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,930
Closed -$84K – 136
2020
Q1 		$84K Buy
+2,930
New +$75.9K 0.03% 101

Other funds holding LVGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
KXA
KPCB XVI Associates Menlo Park, California $225M AUM 26.26% 1-Year Est. Return

ArchPoint Investors's LVGO Position: Q2 2020 in Review

ArchPoint Investors sold out of Livongo Health, Inc. Common Stock (LVGO) in Q2 2020, closing a stake of 2,930 shares — an estimated $84K sold.

ArchPoint Investors first reported a position in LVGO in Q1 2020 and held it in 1 quarter. The position peaked at $84K in Q1 2020. 291 funds tracked by Wall St. Rank hold LVGO as of Q2 2020.

  • ArchPoint Investors reported no remaining Livongo Health, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • ArchPoint Investors sold 2,930 Livongo Health, Inc. Common Stock shares in Q2 2020, an estimated $84K.
  • ArchPoint Investors first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • ArchPoint Investors's Livongo Health, Inc. Common Stock position peaked at $84K in Q1 2020.
  • 291 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q2 2020.

Based on ArchPoint Investors's 13F filing for Q2 2020, filed 31 Jul 2020.